Intalight™ Receives CE Mark for Its Progressive DREAM OCT™ Swept Source Imaging
SAN JOSE, Calif. and SHANGHAI, May 15, 2025 /PRNewswire/ -- Intalight™, a company that develops advanced ophthalmic technologies and a leader...
SAN JOSE, Calif. and SHANGHAI, May 15, 2025 /PRNewswire/ -- Intalight™, a company that develops advanced ophthalmic technologies and a leader...
This Series B round led by General Catalyst, with investments from Andreessen Horowitz (a16z) and other prominent investors, will enable...
GALWAY, Ireland , May 15, 2025 /PRNewswire/ -- Terrence Curtin, chief executive officer of TE Connectivity (NYSE: TEL), a global leader in...
New partnership model empowers pediatric practices to maximize their portal investment with deeper training, dedicated support, and additional engagement solutions...
Company Reports $14.5M in Q1 Revenue; Operating Expenses Decline 26% as Expected, with Continued Focus on Cost Reduction, Efficiency Improvements,...
New Autonomous Workflow Combines Company's PerioLase® MVP-7™ Laser with the Zyris Isolite® Pro System ANAHEIM, Calif., May 15, 2025 /PRNewswire/...
SEOUL, South Korea, May 15, 2025 /PRNewswire/ -- Korean healthtech company MINISH Technology hosted a successful dental seminar and business briefing...
Facing a job market slowdown and growing emotional toll, PARWCC arms résumé writers and career coaches with back-to-back Master Series...
Halifax, Nova Scotia--(Newsfile Corp. - May 15, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is...
Singapore, Singapore--(Newsfile Corp. - May 15, 2025) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or "the Company"), a leading MedTech...
PLAINVIEW, N.Y., May 15, 2025 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO), a leading MedTech company with a diversified...
NATALEE subanalysis evaluates Kisqali in pre-menopausal early breast cancer patients, amid rising diagnosis rates in younger patients Pluvicto analysis and...
TORONTO, May 15, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology...
SAN DIEGO and LONDON and DUBLIN and SYDNEY, May 15, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the...
Company surpasses 450 accounts across 24 countries as global demand for fingerprint drug testing surgesNEW YORK, May 15, 2025 (GLOBE...
Statistically significant safety and efficacy data from 0.25 mg and 0.50 mg cohorts to be presented Presentation scheduled for Thursday,...
SAN FRANCISCO, CALIFORNIA, May 15, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology...
Initiated Phase 2 Seabreeze STAT Asthma and Seabreeze STAT COPD studies evaluating rademikibart as an adjunct treatment for acute exacerbations...
OmniMD unveils AI Clinicians; a bold leap into the future of healthcare. Designed to think like a physician and act...
Fifth annual report reveals growing OEM reliance on CDMOs, M&A momentum, and innovation in polymers and orthopedicsFRAMINGHAM, Mass., May 15,...